Gladstone NOW: The Campaign Join Us on the Journey✕
Isha Jain, PhD, and her team developed a drug that mimics the effects of breathing low oxygen, which could be life-saving for people with mitochondrial diseases who rarely survive past childhood. In mice with Leigh Syndrome—the most common childhood mitochondrial disease—the drug extended lifespan three-fold and reversed symptoms, even when given during late stages of disease. The new drug shows the promise of gas-based therapies for mitochondrial diseases and other common brain and cardiovascular conditions for which low oxygen has been shown to be beneficial.
In this video, Jain and research associate Skyler Blume explain the science behind their discovery and the impact it could have for mitochondrial diseases. Read more about this discovery.
Gladstone NOW: The Campaign
Join Us On The Journey
Gladstone scientists developed a new tool to trace how the brain clears “waste,” uncovering surprising new biology about how it keeps itself healthy.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Yang LabScientists find a gene essential for keeping intestinal stem cells stable, offering insight into how tissues repair themselves.
News Release Research (Publication) Yamanaka Lab Stem Cells/iPSCsA new study upends long-held view about how DNA is stored, explaining how subtle shifts in gene activity contribute to cancer, aging, and other complex diseases.
News Release Research (Publication) Cancer Data Science and Biotechnology Ramani Lab Aging AI